Australian (ASX) Pharmaceuticals & Biotech Dividend Stocks
UPDATED May 03, 2026
Discover Australian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the ASX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VLS | AU$2.55 | -0.8% | 47.4% | AU$137.4m | n/a | 13.3 | n/a | 5.5% | ||
VIT | AU$0.038 | 5.6% | -46.5% | AU$25.8m | n/a | 32.1 | n/a | 5.3% | ||
CSL | AU$124.40 | -5.6% | -51.6% | AU$59.8b | AU$196.39 | 30.8 | 28.1% | 3.3% | ||
CUV | AU$9.25 | 3.0% | -18.5% | AU$462.4m | AU$23.20 | 14.3 | 24.9% | 0.5% | ||
CTE | AU$1.12 | 6.7% | 43.6% | AU$56.1m | n/a | 25.0 | n/a | 0% | ||
MVP | AU$0.46 | -5.2% | -26.0% | AU$53.5m | AU$2.03 | 1.3 | 80.0% | 0% | ||
ACR | AU$0.011 | 0% | -52.2% | AU$4.9m | n/a | 1.6 | n/a | 0% |
Page 1 of 1